Literature DB >> 7542272

Influence of hepatitis C virus (HCV) genotypes on HCV recombinant immunoblot assay patterns.

J M Pawlotsky1, F Roudot-Thoraval, C Pellet, P Aumont, F Darthuy, J Remire, J Duval, D Dhumeaux.   

Abstract

Ninety-six patients with chronic hepatitis C were studied. A second-generation recombinant immunoblot assay detected anti-NS4 antibodies significantly more often in patients infected by hepatitis C virus genotype 1 than in patients infected by other types. By a third-generation recombinant immunoblot assay, the prevalences of the four antibodies measured did not differ according to the hepatitis C virus genotype.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7542272      PMCID： PMC228164          DOI： 10.1128/jcm.33.5.1357-1359.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  16 in total

1.  New kit on the block: evaluation of second-generation assays for detection of antibody to the hepatitis C virus.

Authors:  H J Alter
Journal:  Hepatology       Date:  1992-02       Impact factor: 17.425

2.  A proposed system for the nomenclature of hepatitis C viral genotypes.

Authors:  P Simmonds; A Alberti; H J Alter; F Bonino; D W Bradley; C Brechot; J T Brouwer; S W Chan; K Chayama; D S Chen
Journal:  Hepatology       Date:  1994-05       Impact factor: 17.425

3.  Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3.

Authors:  P Simmonds; K A Rose; S Graham; S W Chan; F McOmish; B C Dow; E A Follett; P L Yap; H Marsden
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

4.  Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease.

Authors:  G Dusheiko; H Schmilovitz-Weiss; D Brown; F McOmish; P L Yap; S Sherlock; N McIntyre; P Simmonds
Journal:  Hepatology       Date:  1994-01       Impact factor: 17.425

5.  Prevalence of hepatitis C virus genotypes in Italy.

Authors:  M Pistello; F Maggi; L Vatteroni; N Cecconi; F Panicucci; G P Bresci; L Gambardella; M Taddei; A Bionda; M Tuoni
Journal:  J Clin Microbiol       Date:  1994-01       Impact factor: 5.948

6.  Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay.

Authors:  L Stuyver; R Rossau; A Wyseur; M Duhamel; B Vanderborght; H Van Heuverswyn; G Maertens
Journal:  J Gen Virol       Date:  1993-06       Impact factor: 3.891

7.  Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey.

Authors:  F McOmish; P L Yap; B C Dow; E A Follett; C Seed; A J Keller; T J Cobain; T Krusius; E Kolho; R Naukkarinen
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

8.  Significance of highly positive c22-3 "indeterminate" second-generation hepatitis C virus (HCV) recombinant immunoblot assay (RIBA) and resolution by third-generation HCV RIBA.

Authors:  J M Pawlotsky; A Fleury; V Choukroun; L Deforges; F Roudot-Thoraval; P Aumont; J Duval; D Dhumeaux
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

9.  Prevalence of antibodies to hepatitis C virus among patients with cryptogenic chronic hepatitis and cirrhosis.

Authors:  L J Jeffers; F Hasan; M De Medina; R Reddy; T Parker; M Silva; L Mendez; E R Schiff; M Manns; M Houghton
Journal:  Hepatology       Date:  1992-02       Impact factor: 17.425

10.  Identification of genotypes of hepatitis C virus by sequence comparisons in the core, E1 and NS-5 regions.

Authors:  P Simmonds; D B Smith; F McOmish; P L Yap; J Kolberg; M S Urdea; E C Holmes
Journal:  J Gen Virol       Date:  1994-05       Impact factor: 3.891
View more
  7 in total

1.  Assessment of commercial enzyme immunoassay for hepatitis C virus serotyping.

Authors:  L M Webber; S Els; M B Taylor; W O Grabow
Journal:  J Clin Pathol       Date:  1996-12       Impact factor: 3.411

2.  Clinical relevance of hepatitis C virus genotypes.

Authors:  P Simmonds
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

Review 3.  Serodiagnosis for tumor viruses.

Authors:  Brian J Morrison; Nazzarena Labo; Wendell J Miley; Denise Whitby
Journal:  Semin Oncol       Date:  2014-12-31       Impact factor: 4.929

4.  Serological determination of hepatitis C virus genotype: comparison with a standardized genotyping assay.

Authors:  J M Pawlotsky; L Prescott; P Simmonds; C Pellet; P Laurent-Puig; C Labonne; F Darthuy; J Remire; J Duval; C Buffet; J P Etienne; D Dhumeaux; E Dussaix
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

5.  Significance of indeterminate third-generation hepatitis C virus recombinant immunoblot assay.

Authors:  J M Pawlotsky; A Bastie; C Pellet; J Remire; F Darthuy; L Wolfe; C Sayada; J Duval; D Dhumeaux
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

6.  Synonymous mutations in the core gene are linked to unusual serological profile in hepatitis C virus infection.

Authors:  Agata Budkowska; Athanassios Kakkanas; Eric Nerrienet; Olga Kalinina; Patrick Maillard; Srey Viseth Horm; Geena Dalagiorgou; Niki Vassilaki; Urania Georgopoulou; Michelle Martinot; Amadou Alpha Sall; Penelope Mavromara
Journal:  PLoS One       Date:  2011-01-06       Impact factor: 3.240

7.  The relationship between virological characteristics of hepatitis C virus (HCV) and reactivity to the regional specific proteins of HCV.

Authors:  S K Yoon; Y M Park; B H Byun; S H Bae; J M Yang; B M Ahn; Y S Lee; C D Lee; H S Sun; B S Kim
Journal:  Korean J Intern Med       Date:  2000-07       Impact factor: 2.884
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.